Browse by author
Lookup NU author(s): Michael Clarke
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Results from recent randomised clinical trials in amblyopia should change our approach to screening for and treatment of amblyopia. Based on the current evidence, if one screening session is used, screening at school entry could be the most reasonable time. Clinicians should preferably use age-appropriate LogMAR acuity tests, and treatment should only be considered for children who are clearly not in the typical range for their age. Any substantial refractive error should be corrected before further treatment is considered and the child should be followed in spectacles until no further improvement is recorded, which can take up to 6 months. Parents and carers should then be offered an informed choice between patching and atropine drops. Successful patching regimens can last as little as 1 h or 2 h a day, and successful atropine regimens as little as one drop twice a week. Intense and extended regimens might not be needed in initial therapy. © 2006 Elsevier Ltd. All rights reserved.
Author(s): Holmes JM, Clarke MP
Publication type: Review
Publication status: Published
Journal: The Lancet
Year: 2006
Volume: 367
Issue: 9519
Pages: 1343-1351
ISSN (print): 0140-6736
ISSN (electronic): 1474-547X
URL: http://dx.doi.org/10.1016/S0140-6736(06)68581-4
DOI: 10.1016/S0140-6736(06)68581-4
PubMed id: 16631913
